Manning & Napier Group’s PHYSICIANS REALTY TRUST DOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-235,224
Closed -$2.87M 239
2023
Q3
$2.87M Buy
235,224
+356
+0.2% +$4.92K 0.04% 208
2023
Q2
$3.29M Buy
+234,868
New +$3.34M 0.04% 215
2020
Q4
Sell
-159,207
Closed -$2.85M 284
2020
Q3
$2.85M Buy
159,207
+32,372
+26% +$577K 0.03% 239
2020
Q2
$2.22M Sell
126,835
-95,745
-43% -$1.56M 0.02% 242
2020
Q1
$3.1M Sell
222,580
-124,235
-36% -$2.28M 0.04% 224
2019
Q4
$6.57M Sell
346,815
-39,490
-10% -$724K 0.07% 184
2019
Q3
$6.86M Sell
386,305
-63,555
-14% -$1.1M 0.08% 186
2019
Q2
$7.84M Sell
449,860
-63,180
-12% -$1.15M 0.09% 170
2019
Q1
$9.65M Sell
513,040
-6,381
-1% -$114K 0.11% 141
2018
Q4
$8.33M Buy
519,421
+34,621
+7% +$580K 0.1% 142
2018
Q3
$8.17M Sell
484,800
-1,580
-0.3% -$26.2K 0.08% 143
2018
Q2
$7.75M Buy
486,380
+66,545
+16% +$1.01M 0.08% 149
2018
Q1
$6.54M Buy
419,835
+180
+0% +$2.82K 0.06% 157
2017
Q4
$7.55M Buy
+419,655
New +$7.53M 0.07% 142

Other funds holding DOC

Manning & Napier Group's DOC Position: Q4 2023 in Review

Manning & Napier Group sold out of PHYSICIANS REALTY TRUST (DOC) in Q4 2023, closing a stake of 235,224 shares — an estimated $2.87M sold.

Manning & Napier Group first reported a position in DOC in Q4 2017 and held it in 14 quarters. The position peaked at $9.65M in Q1 2019. 347 funds tracked by Wall St. Rank hold DOC as of Q4 2023.

  • Manning & Napier Group reported no remaining PHYSICIANS REALTY TRUST position as of Q4 2023 after selling out during the quarter.
  • Manning & Napier Group sold 235,224 PHYSICIANS REALTY TRUST shares in Q4 2023, an estimated $2.87M.
  • Manning & Napier Group first reported a position in PHYSICIANS REALTY TRUST in Q4 2017 and held it in 14 quarters.
  • Manning & Napier Group's PHYSICIANS REALTY TRUST position peaked at $9.65M in Q1 2019.
  • 347 funds tracked by Wall St. Rank held PHYSICIANS REALTY TRUST as of Q4 2023.

Based on Manning & Napier Group's 13F filing for Q4 2023, filed 19 Jan 2024.